The Study Aims to Investigate the Effects of Oral Inositols on Insulin-resistance in Children With Obesity. (ONIRICO)
Obesity, Prediabetic State, Dyslipidemias
About this trial
This is an interventional treatment trial for Obesity focused on measuring INOSITOLS
Eligibility Criteria
Inclusion Criteria: Age under 12 and over 8 years Presence of obesity defined by BMI > 95th percentile of BMI based on the growth curves of the Italian Society of Pediatric Endocrinology and Diabetology (Cacciari curves) Presence of HOMA-IR value (insulin x glycaemia/22.5: marker of insulin resistance) > 75th percentile of a reference pediatric population from Verona Exclusion Criteria: Diabetes mellitus Current chronic disease with systemic inflammation Use of drugs acting on insulin sensitivity (e.g. steroids) Use of food or vitamin supplements up to one month before blood sampling Puberty in progress
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
INOSITOLS
PLACEBO
4000 mg of myo-inositol and 300 mg of D-chiro-inositol. Once a day for 90 days.
Cellulose 4.3 grams once a day for 90 days.